INNT
TOTAL INVALIDATION PROCESSED BY THE IB
09/11/2024
Voltar para busca
Dado oficial do USPTO
LIPID INCODE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
LIPID INCODE
ST13
US500000079186567Classe
5, 10, 42, 44
Pedido
79186567
Registro
5248111
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
48
Atualização mais recente
09/11/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10, 42, 44
Data de depósito
07/03/2016
Data de registro
25/07/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/02/2024
Última transação
09/02/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
O'BRIEN, JENNIFER LYNN
Unidade examinadora
N20
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
GENINCODE U.K., LTD.
FERRER INCODE, S.L.
Representantes
LEIGH ANN LINDQUIST SUGHRUE MION, PLLC
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Diagnostic preparations for medical or veterinary purposes; productsreagents and indicators for medical diagnosticspreparationsreagents and biological indicators for monitoring the diagnosis of Familiar Hypercholesterolemia as well as DLAL (Deficiency in Lysosomal Acid Lipase) for medical or veterinary purposes; Diagnostic agents for medical purposesdiagnostic agents for pharmaceutical use; testing materials for medical usemedical diagnostic reagents and assays for testing of body fluids; pharmaceutical and veterinary productspharmaceutical products for the treatment of Hypercholesterolemia; food supplements for humans or animals; nutraceutical products for therapeutic use and as a dietary supplementnutraceuticals for the treatment of Hypercholesterolemia and nutraceuticals for use as a dietary supplement; Plasters for medical purposesmaterial for dressings; disinfectants
Classe 10
Surgicalmedicaldental and veterinary instruments and apparatusmedical instruments and apparatus for use in a genetic diagnostic kit in the diagnosis of Familiar Hypercholesterolemia as well as DLAL (Deficiency in Lysosomal Acid Lipase) procedures; suture materials; instruments and apparatus for medical diagnosticsapparatus for medical diagnostic testing in the fields of Familiar Hypercholesterolemia as well as DLAL (Deficiency in Lysosomal Acid Lipase); automatic analyzers for medical diagnosticsmedical diagnostic instruments for the analysis of body fluids; apparatus for diagnostic testing for medical purposesmedical diagnostic apparatus for testing DNA; diagnostic test kits for detecting diseasesdiagnostic kits consisting primarily of probesbuffers and reagents for use in genetic body fluids testing; apparatus for analyzing DNA in biological samples for medical use; apparatus for collecting samples of body fluidsmedical specimen collection devices in the nature of glass slidescups or bags for the collection of blood or saliva samples; Medical specimen bags for testing purposesbags for medical use in storing blood or saliva samples; Medical specimen bags for testing purposesbags for medical use in collecting blood or saliva samples; Sample preparation device for medical diagnostic usessample preparation columns for medical use; containers for medical samplesblood and saliva containers for medical purposes; devices for taking samples for medical usemedical devices for obtaining body fluid samples; urine sample testing instruments for medical diagnostics in the nature of medical diagnostic apparatus for testing DNA; containers specially designed for transporting samples containing living human cells; holders for sample containersspecimen cup holders; capillary tubes for samples
Classe 42
Medical and pharmaceutical research services; research and development services in the field of bacteriology; scientific research services for medical purposes in the field of Familiar HypercholesterolemiaDLAL (Deficiency in Lysosomal Acid Lipase) and Cardiovascular Risks; chemical research and analysis; advisory services relating to pharmaceutical research; technical project studyscientific study and research in the field of the preventiontreatment and management of Familiar HypercholesterolemiaDLAL (Deficiency in Lysosomal Acid Lipase) and Cardiovascular Risks; medical research laboratory services; design and development of apparatus for medical diagnostics; computer-assisted diagnostic testing servicesdiagnostic services in the field of Familiar HypercholesterolemiaDLAL (Deficiency in Lysosomal Acid Lipase) and Cardiovascular Risks; Scientific laboratory servicespreparation of biological samples for research purposes; Scientific laboratory servicespreparation of biological samples for use in testing and analysis in research laboratories
Classe 44
Medical services; diagnosis of diseasesmedical diagnosis of Familiar HypercholesterolemiaDLAL (Deficiency in Lysosomal Acid Lipase) and Cardiovascular Risks; medical diagnostic servicestesting and analysismedical diagnostic testingmonitoring and reporting services; genetic testing for diagnostics or treatments for medical purposes; medical information services provided on the Internetreporting of consumer authorized clinical testing results directly to the patient; Medical consultation and information services in the field of medical productsproviding information relating to diagnosticprophylactic and treatment of Familiar HypercholesterolemiaDLAL (Deficiency in Lysosomal Acid Lipase) and Cardiovascular Risks; medicalmedicinal and pharmaceutical consultation services; medical advisory services; medical information servicesproviding medical information; medical analyses for the diagnosis and treatment of peopleproviding medical profiles and medical record analysis and assessments via a website that are designed to provide custom tailored outputs about recommended resources and treatments associated with a defined set of symptoms and concernsproviding on-line medical record analysis services designed to provide patients with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms; Medical testing for diagnostic or treatment purposesmedical testing relating to the diagnosis and treatment of people; Medical testing for diagnostic or treatment purposesmedical laboratory services for the analysis of blood and saliva samples; Medical testing for diagnostic or treatment purposesmedical laboratory services for the analysis of samples obtained from patients; Medical testing for diagnostic or treatment purposesmedical laboratory services for the analysis of blood and saliva samples obtained from patients
Publicações
Histórico de despachos e eventos da marca no USPTO.
48 publicações encontradas
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
24/10/2024
INPC
INVALIDATION PROCESSED
24/10/2024
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
10/10/2024
C71T
CANCELLED SECTION 71
09/02/2024
NREP
NEW REPRESENTATIVE AT IB RECEIVED
24/12/2022
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
25/07/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/07/2021
CHLD
CHANGE OF OWNER RECEIVED FROM IB
18/12/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
20/11/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
20/11/2019
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
24/11/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/11/2017
FIMP
FINAL DISPOSITION PROCESSED
03/11/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
25/10/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
25/07/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/05/2017
PUBO
PUBLISHED FOR OPPOSITION
09/05/2017
GPNX
NOTIFICATION PROCESSED BY IB
05/05/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
19/04/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
19/04/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
19/04/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
31/03/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
27/03/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
27/03/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
27/03/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
27/03/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
27/03/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
18/02/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
18/02/2017
ALIE
ASSIGNED TO LIE
16/02/2017
NREV
NOTICE OF REVIVAL - E-MAILED
06/02/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/02/2017
PETG
PETITION TO REVIVE-GRANTED
03/02/2017
PROA
TEAS PETITION TO REVIVE RECEIVED
03/02/2017
MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
26/01/2017
ABN2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
25/01/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/10/2016
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/10/2016
RFNT
REFUSAL PROCESSED BY IB
16/07/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
28/06/2016
RFRR
REFUSAL PROCESSED BY MPU
28/06/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
28/06/2016
CNRT
NON-FINAL ACTION WRITTEN
27/06/2016
DOCK
ASSIGNED TO EXAMINER
20/06/2016
MAFR
APPLICATION FILING RECEIPT MAILED
10/05/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/05/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/05/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace LIPID INCODE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.